Table 13.6b

Immunosuppression Used for Maintenance Prior to Discharge, 1993 to 2002

Recipients with Heart-Lung Transplants

		Year of Transplant
		1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Functioning Graft at Discharge		48	55	60	28	39	33	36	35	21	21
With Immunosuppression Info		48	53	60	25	37	31	35	35	21	21
Corticosteroids	Category Usage	91.7%	100.0%	96.7%	88.0%	94.6%	90.3%	100.0%	100.0%	100.0%	100.0%
	Steroids	91.7%	100.0%	96.7%	88.0%	94.6%	90.3%	100.0%	100.0%	100.0%	100.0%
Cyclosporine	Category Usage	85.4%	92.5%	75.0%	68.0%	70.3%	71.0%	62.9%	80.0%	71.4%	61.9%
	Cyclosporin	85.4%	90.6%	73.3%	4.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	0.0%	1.9%	1.7%	12.0%	5.4%	12.9%	17.1%	8.6%	9.5%	14.3%
	Neoral	0.0%	0.0%	0.0%	52.0%	64.9%	61.3%	51.4%	71.4%	61.9%	47.6%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	2.9%	4.8%	4.8%
Tacrolimus	Category Usage	12.5%	1.9%	13.3%	20.0%	32.4%	32.3%	40.0%	31.4%	23.8%	42.9%
	FK506	12.5%	1.9%	13.3%	20.0%	32.4%	32.3%	40.0%	31.4%	23.8%	42.9%
Antimetabolites	Category Usage	93.8%	98.1%	95.0%	88.0%	94.6%	83.9%	82.9%	91.4%	95.2%	95.2%
	Azathioprine	93.8%	98.1%	95.0%	68.0%	75.7%	51.6%	37.1%	48.6%	42.9%	52.4%
	Mycophenolate mofetil	0.0%	0.0%	1.7%	24.0%	21.6%	38.7%	51.4%	51.4%	52.4%	47.6%
Other	Category Usage	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Cytoxan	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Source: OPTN/SRTR Data as of August 1, 2003.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.